Common side effects include: Mild to Moderate Side Effects Nausea Vomiting Diarrhea or constipation Abdominal discomfort Appetite changes Headache Less Common Side Effects: Dizziness Fatigue Injection site reactions Temporary hypoglycemia when combined with other diabetes medications Rare but Serious Side Effects: Pancreatitis: Severe abdominal pain that may radiate to the back Gallbladder disease: Increased risk of gallstones Kidney issues: Worsening kidney function in some patients Thyroid tumors: Observed in animal studies, though human risk is unclear To minimize side effects, we recommend: Important Considerations Before Starting Semaglutide Medical History: Not recommended for individuals with a history of pancreatitis or thyroid cancer
GLP-1 drug penetration below 4% of eligible patients Top GLP-1 market: United States with 62.8% of global GLP-1 weight loss drug revenue Cardiovascular approval catalyst: Wegovy approved for MACE risk reduction following SELECT trial demonstrating 20% reduction in major adverse cardiovascular events Fastest-growing indication: Obstructive sleep apnea at 41.2% CAGR following Zepbound FDA approval November 2025 Market Overview: Why GLP-1 Weight Loss Drug Market Growth Is Accelerating The GLP-1 Weight Loss Drug Market is at an unprecedented commercial inflection point defined by three simultaneous demand accelerators
This is just another tool to support my health journey. Serena began a GLP-1 regimen about a year ago, once she finished breastfeeding Adira
Mounjaro Clinically Proven Obesity Treatment & Weight Loss Medication Mounjaro is an injectable prescription medicine that is used along with diet and exercise to help patients lose weight
These effects were subsequently managed through slower absorption kinetics, extended dosing intervals, and careful titration, allowing therapeutic benefit to outweigh adverse events (Drucker, 2018)
Always check concentration on your vial label before drawing up
